Sun Pharma's FEXUCLUE: The Game-Changing Treatment for Erosive Esophagitis

Unknown Apr 02, 2026 600 Views

Sun Pharmaceutical Industries Limited has achieved a major milestone in the history of Indian pharma by introducing FEXUCLUE (Fexuprazan) 40 mg tablets, a new potassium-competitive acid blocker (PCAB), for the management of erosive esophagitis. This launch is a part of Sun Pharma's strategic...